Inactive Instrument

Analyst Reco. Pardes Biosciences, Inc.

Equities

SVB Securities Downgrades Pardes Biosciences to Market Perform From Outperform, Lowers Price Target to $2 From $9	23-04-04	MT
Jefferies Downgrades Pardes Biosciences to Hold From Buy, Lowers Price Target to $1.25 From $10	23-04-03	MT
JMP Securities Adjusts Price Target on Pardes Biosciences to $5 From $9, Maintains Market Outperform Rating	23-03-15	MT
SVB Securities Adjusts Pardes Biosciences' Price Target to $9 From $12, Keeps Outperform Rating	23-01-27	MT
JMP Securities Starts Pardes Biosciences at Market Outperform With $9 Price Target	22-12-13	MT
Jefferies Adjusts Pardes Biosciences' Price Target to $10 from $20, Keeps Buy Rating	22-08-16	MT
SVB Securities Adjusts Pardes Biosciences' Price Target to $12 from $18, Keeps Outperform Rating	22-08-16	MT
SVB Leerink Starts Pardes Biosciences at Outperform with $18 Price Target	22-03-15	MT
Jefferies Starts Pardes Biosciences at Buy with $25 Price Target	22-01-18	MT
ANALYST RECOMMENDATIONS : Admiral, Hiscox, National Grid, Qiagen, Unilever...	22-01-17

No results for this search